{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:57:52Z","timestamp":1791284272953,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Rosacea is a chronic inflammatory dermatosis characterized by remissions and flares. Although the rosacea active treatment phase is well established, the long\u2010term maintenance phase is still challenging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To discuss and make recommendations on how to treat patients during the long\u2010term maintenance phase for the main rosacea phenotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A panel of six board\u2010certified Brazilian dermatologists and one American dermatologist gathered to compose a consensus based upon an initial statement on how to treat rosacea during the long\u2010term maintenance phase based on the methodology Nominal Group Technique. The experts discussed each factor based upon an initial statement on how to treat rosacea patients in the long\u2010term maintenance phase. A sequence of comprehensive narrative reviews was performed; a questionnaire preparation about the definition of the maintenance phase and its management was presented; an interpersonal discussion and ranking of the ideas were conducted. Recommendations were made if the specialists had 75% agreement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The maintenance treatment phase, which starts by achieving IGA 0 or 1 grades at the active phase, should be considered at least during the 9\u2010month period after remission. The recommendations of all treatments target this period. Daily skincare regimen and sunscreen are crucial. Active treatment phase should be recommended if signs or symptoms reappear or worsen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Maintenance phase success depends on patient's adherence to daily skin care, appropriate treatments, continued follow\u2010up with dermatologist, and self\u2010assessment to identify new signs and symptoms indicating disease relapse.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijd.16920","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T08:24:23Z","timestamp":1701159863000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long\u2010term maintenance treatment of rosacea: experts' opinion"],"prefix":"10.1111","volume":"63","author":[{"given":"Luiz M. C.","family":"Almeida","sequence":"first","affiliation":[{"name":"Department of Dermatology Santa Casa de Belo Horizonte  Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3128","authenticated-orcid":false,"given":"Mayra","family":"Ianhez","sequence":"additional","affiliation":[{"name":"Hospital of Tropical Diseases, Universidade Federal de Goi\u00e1s Faculdade de Medicina  Goi\u00e2nia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taciana","family":"Dal'Forno","sequence":"additional","affiliation":[{"name":"Dermatology Residency Program Pontificia Universidade Catolica do Rio Grande do Sul Porto Alegre, Private Practice  Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola R.","family":"Picosse","sequence":"additional","affiliation":[{"name":"Department of Dermatology Universidade Federal de S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Ravelli","sequence":"additional","affiliation":[{"name":"Private Practice  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christhine","family":"Kamamoto","sequence":"additional","affiliation":[{"name":"Galderma  S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Sarlos","sequence":"additional","affiliation":[{"name":"Private Practice  Rio de Janeiro Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda F. S.","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Dermatology Henry Ford Medical Centre  Detroit MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.037"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15173"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1506630"},{"key":"e_1_2_6_5_1","first-page":"323","article-title":"Cutaneous and ocular rosacea: common and specific physiopathogenic mechanisms and study models","volume":"27","author":"Rodrigues\u2010Braz D","year":"2021","journal-title":"Mol Vis"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16534"},{"key":"e_1_2_6_7_1","first-page":"239","article-title":"Incidence and prevalence of rosacea: a systematic reviewand meta\u2010analysis","volume":"179","author":"Gether L","year":"2018","journal-title":"Br J Dermatol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2397"},{"issue":"6","key":"e_1_2_6_9_1","first-page":"17","article-title":"Update on the management of rosacea from the American Acne & Rosacea Society (AARS)","volume":"12","author":"Rosso JQ","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18420"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.08.001"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15122"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2021.09.006"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000001092"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/0142159X.2017.1245856"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13537"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1343435"},{"issue":"11","key":"e_1_2_6_19_1","first-page":"1380","article-title":"Long\u2010term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40\u2010week controlled, investigator\u2010blinded trials","volume":"13","author":"Stein Gold L","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.027"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.03.033"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23439"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00458-9"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02277-0"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15395"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1360991"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.129"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.204"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.04.017"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13370"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.09.001"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231078"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02095-w"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17590"},{"issue":"10","key":"e_1_2_6_35_1","first-page":"2285","article-title":"Botulinum toxin A alleviates persistent erythema and flushing in patients with erythema telangiectasia rosacea","volume":"12","author":"Yang R","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102875"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15680"},{"issue":"1","key":"e_1_2_6_38_1","article-title":"Long\u2010term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified\u2010release capsules once daily","volume":"35","author":"Rosso JQ","year":"2022","journal-title":"Dermatol Ther"},{"issue":"11","key":"e_1_2_6_39_1","first-page":"44","article-title":"Open\u2010label extension study evaluating long\u2010term safety and efficacy of FMX103 1.5% minocycline topical treatment of moderate\u2010to severe papulopustular rosacea","volume":"13","author":"Stein Gold L","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0133-6"},{"issue":"7","key":"e_1_2_6_41_1","first-page":"E60","article-title":"How to optimize rosacea treatment for better patient outcomes: an opinion piece","volume":"15","author":"Schaller M","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12522"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14986"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0526"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.11.022"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2020.04.011"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.16920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T11:53:57Z","timestamp":1744545237000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.16920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/ijd.16920"],"URL":"https:\/\/doi.org\/10.1111\/ijd.16920","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"2023-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}